Ali Bektaş

Dr. Ali Bektaş

Oakland Genomics Center

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2019 in Plant Disease
Verified
Journal Article
Open access
ABAli Bektaş
Ali Bektaş
KHKayla M. Hardwick
Kayla M. Hardwick
KWKristen Waterman
Kristen Waterman
JKJessica Kristof
Jessica Kristof
In February 2018 we sampled three symptomatic and three asymptomatic Cannabis plants suspected to host a viral agent from a farm in Santa Barbara County, CA. The symptoms included brittle stems, an outwardly horizontal plant structure and reduced flower mass and trichomes. RNA from each flower sample was extracted using a QIAmp Viral Mini Kit (Qiagen, Hilden, Germany). RNA was purified, concentrated, and ribo-depleted before library construction with NEBNext Ultra II Directional RNA kit (NEB, Ipswich, MA). Individual libraries were tagged with unique adapters and pooled for sequencing with a NextSeq High Output 300 cycle kit (Illumina, San Diego, CA). Sequence data was assembled with Trinity (Grabherr et al. 2011), and Blobtools (Laetsch and Blaxter, 2017) was used to search for viral sequences. Possible viral transcripts were filtered for at least 10x coverage, 95% BLAST identity, and alignment length greater than 80% of query and subject sequences. One hundred and twenty-five transcripts showed signific...

23 April 2021 in Viruses
Verified
Journal Article
Open access
PDF file
ABAli Bektaş
Ali Bektaş
MCMichael Covington
Michael Covington
GAGuy Aidelberg
Guy Aidelberg
AAAnibal Arce
Anibal Arce
TMTamara Matute
Tamara Matute
AJAnitha Jayaprakash
Anitha Jayaprakash
The coronavirus disease 2019 (COVID-19) pandemic has highlighted bottlenecks in large-scale, frequent testing of populations for infections. Polymerase chain reaction (PCR)-based diagnostic tests are expensive, reliant on centralized labs, can take days to deliver results, and are prone to backlogs and supply shortages. Antigen tests that bind and detect the surface proteins of a virus are rapid and scalable but suffer from high false negative rates. To address this problem, an inexpensive, simple, and robust 60-minute do-it-yourself (DIY) workflow to detect viral RNA from nasal swabs or saliva with high sensitivity (0.1 to 2 viral particles/μL) and specificity (>97% true negative rate) utilizing reverse transcription loop-mediated isothermal amplification (RT-LAMP) was developed. ALERT (Accessible LAMP-Enabled Rapid Test) incorporates the following features: (1) increased shelf-life and ambient temperature storage, compared to liquid reaction mixes, by using wax layers to isolate enzymes from other reagents; (2) improved specificity compared to other LAMP end-point reporting methods, by using sequence-specific QUASR (quenching of unincorporated amplification signal reporters); (3) increased sensitivity, compared to methods without purification through use of a magnetic wand to enable pipette-free concentration of sample RNA and cell debris removal; (4) quality control with a nasopharyngeal-specific mRNA target; and (5) co-detection of other respiratory viruses, such as influenza B, by multiplexing QUASR-modified RT-LAMP primer sets. The flexible nature of the ALERT workflow allows easy, at-home and point-of-care testing for individuals and higher-throughput processing for labs and hospitals. With minimal effort, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific primer sets can be swapped out for other targets to repurpose ALERT to detect other viruses, microorganisms, or nucleic acid-based markers.

22 September 2017 in Food Analytical Methods
Verified
Journal Article
Closed access
PDF file
ABAli Bektaş
Ali Bektaş

20 February 2021 in medRxiv
Verified
Preprint
Open access
PDF file
ABAli Bektaş
Ali Bektaş
MCMichael Covington
Michael Covington
GAGuy Aidelberg
Guy Aidelberg
AAAnibal Arce
Anibal Arce
TMTamara Matute
Tamara Matute
AJAnitha Jayaprakash
Anitha Jayaprakash
The COVID-19 pandemic has highlighted bottlenecks in large-scale, frequent testing of populations for infections. PCR-based diagnostic tests are expensive, reliant on expensive centralized labs, can take days to deliver results, and are prone to backlogs and supply shortages. Antigen tests, that bind and detect the surface proteins of a virus, are rapid and inexpensive but suffer from high false negative rates. To address this problem, we have created an inexpensive, simple, and robust 60-minute Do-It-Yourself (DIY) workflow to detect viral RNA from nasal swabs or saliva with high sensitivity (0.1 to 2 viral particles/ µ l) and specificity (>97% True Negative Rate) utilizing reverse transcription loop-mediated isothermal amplification (RT-LAMP). Our workflow, ALERT (Accessible LAMP-Enabled Rapid Test), incorporates the following features: 1) Increased shelf-life and ambient temperature storage by using wax layers to isolate enzymes from reaction, 2) Improved specificity by using sequence-specific QUASR reporters, 3) Increased sensitivity through use of a magnetic wand to enable pipette-free concentration of sample RNA and cell debris removal, 4) Quality control with a nasopharyngeal-specific mRNA target, and 5) Co-detection of other respiratory viruses, such as Influenza B, by duplexing QUASR-modified RT-LAMP primer sets. The flexible nature of the ALERT workflow allows easy, at-home and point-of-care testing for individuals and higher-throughput processing for centralized labs and hospitals. With minimal effort, SARS-CoV-2-specific primer sets can be swapped out for other targets to repurpose ALERT to detect other viruses, microorganisms or nucleic acid-based markers.